Design of the silent cerebral infarct transfusion (SIT) trial

Pediatric Hematology and Oncology

Volumn 27, Issue 2, 2010, Pages 69-89

  Casella, James F ^a   King, Allison A ^b   Barton, Bruce ^c   White, Desiree A ^b   Noetzel, Michael J ^b   Ichord, Rebecca N ^d   Terrill, Cindy ^b   Hirtz, Deborah ^e   McKinstry, Robert C ^b   Strouse, John J ^a   Howard, Thomas H ^f   Coates, Thomas D ^g   Minniti, Caterina P ^h   Campbell, Andrew D ⁱ   Vendt, Bruce A ^b   Lehmann, Harold ^a   Debaun, Michael R ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c MARYLAND MEDICAL RESEARCH INSTITUTE   (United States)

^d CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g CHILDREN S HOSPITAL LOS ANGELES   (United States)

^h CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Blood transfusion therapy; Clinical trials; Hemoglobinopathies; Sickle cell anemia; Silent cerebral infarcts

Indexed keywords

DNA;

ARTICLE; BLOOD SAMPLING; BLOOD TRANSFUSION; BRAIN INFARCTION; CHILD; CLINICAL OBSERVATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; METHODOLOGY; MORBIDITY; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCREENING; STROKE;

ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; CEREBRAL INFARCTION; CHILD; HUMANS; MAGNETIC RESONANCE IMAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; STROKE;

EID: 77749243156     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880010903360367     Document Type: Article

References (28)

1. Ashley-Koch A, Yang Q, Olney RS. Sickle hemoglobin (HbS) allele and sickle cell disease: a HuGE review. Am J Epidemiol. 2000;151:839-845.
2. Earley CJ, Kittner SJ, Feeser BR, et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology. 1998;51:169-176.
3. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998;91:288-294.
4. Glauser TA, Siegel MJ, Lee BC, DeBaun MR. Accuracy of neurologic examination and history in detecting evidence of MRI-diagnosed cerebral infarctions in children with sickle cell hemoglobinopathy. J Child Neurol. 1995;10:88-92.
5. Pegelow CH, Macklin EA, Moser FG, et al. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002;99:3014-3018.
6. Kwiatkowski JL, Zimmerman RA, Pollock AN, et al. Silent infarcts in young children with sickle cell disease. Br J Haematol. 2009;146:300-305.
7. Schatz J, Brown RT, Pascual JM, et al. Poor school and cognitive functioning with silent cerebral infarcts and sickle cell disease. Neurology. 2001;56:1109-1111.
8. Armstrong FD, Thompson RJ, Jr., Wang W, et al. Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996;97:864-870.
9. Moran CJ, Siegel MJ, DeBaun MR. Sickle cell disease: imaging of cerebrovascular complications. Radiology. 1998;206:311-321.
10. Moser FG, Miller ST, Bello JA, et al. The spectrum of brain MR abnormalities in sickle-cell disease: A report from the Cooperative Study of Sickle Cell Disease. AJNR Am J Neuroradiol. 1996;17:965-972.
11. Baird RL, Weiss DL, Ferguson AD, et al. Studies in sickle cell anemia: XXI. Clinico-pathological aspects of neurological manifestations. Pediatrics. 1964;34:92-100.
12. King AA, Noetzel M, White DA, et al. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts. Pediatr Blood Cancer. 2008;50:599-602.
13. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials. BMJ. 1999;319:670-674.
14. Adams RJ, McKie VC, Hsu L, et al. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography. New Engl J Med. 1998;339:5-11.
15. Scothorn DJ, Price C, Schwartz D, et al. Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial stroke. J Pediatr. 2002;140:348-354.
16. Pegelow CH, Wang W, Granger S, et al. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity. Arch Neurol. 2001;58:2017-2021.
17. Landgraf JM. CHQ Manual. Boston: Health Act; 2000.
18. Nixon SK, Maunsell E, Desmeules M, et al. Mutual concurrent validity of the child health questionnaire and the health utilities index: an exploratory analysis using survivors of childhood cancer. Int J Cancer Suppl. 1999;12:95-105.
19. Wechsler D. Wechsler Abbreviated Scale of Intelligence Manual. San Antonio: The Psychological Corporation; 1999.
20. Wechsler D. Wechsler Pre-School and Primary Scale of Intelligence, WPPSI. New York: The Psychological Corporation; 1967.
21. Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior Rating Inventory of Executive Function. Lutz: Psychological Assessment Resources; 2000.
22. Raskino C, Pearson DA, Baker CJ, et al. Neurologic, neurocognitive, and brain growth outcomes in human immunodeficiency virus-infected children receiving different nucleoside antiretroviral regimens. Pediatric AIDS Clinical Trials Group 152 Study Team. Pediatrics. 1999;104:e32.
23. Ryan C, Adams KM, Heaton RK, Grant I. Neurobehavioral assessment of medical patients in clinical trials: the DCCT experience. In: Mohr EBP, ed. Handbook of Clinical Trials: The Neurobehavioral Approach. Amsterdam/Lisse: Swets & Zeitlinger BV; 1991:215-242.
24. Ichord R, Smith S, Garcia-Espana F, et al. Pediatric adaptation of NIH stroke scale predicts outcome after arterial ischemic stroke in children. Stroke. 2005;36:480-481. (Abstract)
25. Hurtig AL, White LS. Psychosocial adjustment in children and adolescents with sickle cell disease. J Pediatr Psychol. 1986;11:411-427.
26. Armitage P. Exclusions, losses to follow-Up, and withdrawals in clinical trials. In: Shapiro SLT, ed. Clinical Trials: Issues and Approaches. New York: Marcel Dekker; 1983:99-113.
27. Buchanan GR, DeBaun MR, Quinn CT, Steinberg MH. Sickle cell disease. Hematology Am Soc Hematol Educ Program. 2004;35-47.
28. Craft S, Schatz J, Glauser TA, et al. Neuropsychologic effects of stroke in children with sickle cell anemia. J Pediatr. 1993;123:712-717.